All In Biotech

Drug Trial Radar · NCT00000525

Diuretics, Hypertension, and Arrhythmias Clinical Trial

Last checked: Nov 19, 2026Latest source record: Sep 19, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 233 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

233

Actual

Start

Jul 1986

Primary completion

Sep 1989

Sponsor

Lead sponsor
University of California, San FranciscoAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
First posted
Oct 28, 1999

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Masking
Double
Who can join
Male only, from 35 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To determine whether hypertensive patients with ECG abnormalities and receiving hydrochlorothiazide diuretics were at increased risk of sudden death.

Conditions

  • Cardiovascular Diseases
  • Death, Sudden, Cardiac
  • Heart Arrest
  • Heart Diseases
  • Hypertension

Interventions

  • hydrochlorothiazideDrug

  • diet, potassium supplementationBehavioral

  • diet, magnesium supplementationBehavioral

  • triamtereneDrug

  • chlorthalidoneDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.